Related Experiment Video
Updated: Dec 14, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Gypenoside Inhibits Endothelial Cell Apoptosis in Atherosclerosis by Modulating Mitochondria through PI3K/Akt/Bad
Nan Song1,2, Lianqun Jia1,2, Huimin Cao1,2
1Key Laboratory of Ministry of Education for TCM Viscera-State Theory and Applications, Liaoning University of Traditional Chinese Medicine, Shenyang 110847, China.
Insights
Gypenoside, a natural compound, reduces atherosclerosis by protecting endothelial cells from apoptosis. It modulates mitochondrial function and the PI3K/Akt/Bad pathway, offering therapeutic potential for this common disease.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Pharmacology
Background:
- Atherosclerosis is a leading global cause of mortality.
- Endothelial cell apoptosis contributes significantly to atherosclerosis progression by impairing lipid homeostasis, inflammation, and immune regulation.
- Endothelial injury disrupts barrier function, promoting lipid deposition and atherogenesis.
Purpose of the Study:
- To investigate the potential of gypenoside, a natural product derived from Chinese medicine, in preventing and treating atherosclerosis.
- To elucidate the molecular mechanisms underlying gypenoside's effects on endothelial cell apoptosis and mitochondrial function in atherosclerosis.
Main Methods:
- Administration of gypenoside to a mouse model of atherosclerosis.
- Assessment of serum lipid levels, atherosclerotic plaque formation, and aortic intima thickening.
- Analysis of the PI3K/Akt/Bad signaling pathway and apoptosis-related protein expression in the aorta.
- Evaluation of mitochondrial fission and fusion proteins, and mitochondrial energy-related proteins.
Main Results:
- Gypenoside treatment decreased serum lipid levels, alleviated atherosclerotic plaque formation, and reduced aortic intima thickening.
- Gypenoside activated the PI3K/Akt/Bad signaling pathway, modulating apoptosis-related protein expression.
- Gypenoside downregulated mitochondrial fission and fusion proteins, and mitochondrial energy-related proteins in mouse aortas.
Conclusions:
- Gypenoside exhibits a protective effect against atherosclerosis by mitigating endothelial cell apoptosis.
- Gypenoside's therapeutic potential lies in its ability to modulate mitochondrial function via the PI3K/Akt/Bad pathway.
- Gypenoside represents a promising natural therapeutic agent for atherosclerosis associated with endothelial apoptosis.
Abstract:
Atherosclerosis remains the most common cause of deaths worldwide. Endothelial cell apoptosis is an important process in the progress of atherosclerosis, as it can cause the endothelium to lose their capability in regulating the lipid homeostasis, inflammation, and immunity. Endothelial cell injury can disrupt the integrity and barrier function of an endothelium and facilitate lipid deposition, leading to atherogenesis. Chinese medicine techniques for preventing and treating atherosclerosis are gaining attention, especially natural products. In this study, we demonstrated that gypenoside could decrease the levels of serum lipid, alleviate the formation of atherosclerotic plaque, and lessen aortic intima thickening. Gypenoside potentially activates the PI3K/Akt/Bad signal pathway to modulate the apoptosis-related protein expression in the aorta. Moreover, gypenoside downregulated mitochondrial fission and fusion proteins, mitochondrial energy-related proteins in the mouse aorta. In conclusion, this study demonstrated a new function of gypenoside in endothelial apoptosis and suggested a therapeutic potential of gypenoside in atherosclerosis associated with apoptosis by modulating mitochondrial function through the PI3K/Akt/Bad pathway.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Related Concept Videos
The Intrinsic Apoptotic Pathway
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
Apoptosis
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway